Latham & Watkins LLP represents Lyra Therapeutics on the transaction Lyra Therapeutics, Inc. (Nasdaq: LYRA) has announced the pricing of its initial public offering of 3,500,000…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now